Related Experiment Video
Updated: Nov 24, 2025

Therapeutic Evaluation of Fecal Microbiota Transplantation in an Interleukin 10-Deficient Mouse Model
Published on: April 6, 2022
[Diet therapy for irritable bowel syndrome].
I G Bakulin1, E B Avalueva1, L S Оrеshkо1
1Mechnikov North-Western State Medical University.
This review explores irritable bowel syndrome (IBS) pathogenesis and contributing factors. It highlights promising dietary interventions like the low-FODMAP and gluten-free diets for managing IBS symptoms effectively.
Area of Science:
- Gastroenterology
- Nutrition Science
- Medical Research
Background:
- Irritable bowel syndrome (IBS) is a prevalent gastrointestinal disorder characterized by abdominal pain and altered bowel habits.
- The exact pathogenesis of IBS remains multifactorial, involving complex interactions between the gut-brain axis, immune system, and microbial environment.
- Understanding the interplay of endogenous and exogenous factors is crucial for developing effective management strategies.
Purpose of the Study:
- To review current knowledge on the pathogenesis of irritable bowel syndrome (IBS).
- To examine the influence of endogenous and exogenous factors on IBS symptom development.
- To evaluate the efficacy of various dietary therapies, including traditional and novel approaches, for IBS management.
Main Methods:
- Systematic literature review of studies on IBS pathogenesis and diet therapy.
- Analysis of research investigating the role of genetic, environmental, and lifestyle factors in IBS.
- Evaluation of clinical trials and observational studies assessing the impact of dietary interventions on IBS symptoms.
Main Results:
- The pathogenesis of IBS involves a complex interplay of visceral hypersensitivity, altered gut motility, and neuro-immune dysregulation.
- Both internal biological factors and external influences like diet and stress contribute significantly to IBS symptom onset and severity.
- The low-FODMAP (Fermentable Oligosaccharides, Disaccharides, Monosaccharides, and Polyols) diet and gluten-free diet demonstrate significant potential in alleviating IBS symptoms for a substantial proportion of patients.
Conclusions:
- Dietary interventions play a pivotal role in the management of IBS, offering a viable therapeutic avenue.
- The low-FODMAP and gluten-free diets represent promising, evidence-based strategies for improving the quality of life for individuals with IBS.
- Further research is warranted to elucidate the precise mechanisms underlying dietary responses in IBS and to personalize treatment approaches.
Related Concept Videos
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Drugs for Treatment of Diarrhea-Predominant IBS
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Irritable Bowel Syndrome III: Medical and Nursing Management
Drugs for Treatment of Constipation-Predominant IBS
Irritable Bowel Syndrome I: Introduction
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:

